Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Tislelizumab produces long-term benefits in relapsed, refractory classical Hodgkin lymphoma

Tislelizumab produces long-term benefits in relapsed, refractory classical Hodgkin lymphoma

01 Apr 2022
Empagliflozin benefits similar between MRA users, nonusers

Empagliflozin benefits similar between MRA users, nonusers

31 Mar 2022

In patients with heart failure (HF) and preserved ejection fraction, treatment with empagliflozin delivers comparable benefits in reducing first hospitalization for HF or cardiovascular death (primary outcome) between users and nonusers of mineralocorticoid receptor antagonists (MRA), reports a study.

Empagliflozin benefits similar between MRA users, nonusers

31 Mar 2022
DOACs, LMWH prevent VTE, but increase bleeding, in major noncardiac surgery

DOACs, LMWH prevent VTE, but increase bleeding, in major noncardiac surgery

30 Mar 2022
Methenamine hippurate prevents recurrent UTI in women

Methenamine hippurate prevents recurrent UTI in women

29 Mar 2022